BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 90 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,835,000 | +45.1% | 205,255 | +36.4% | 0.08% | +31.6% |
| Q4 2017 | $1,265,000 | -0.1% | 150,426 | +37.2% | 0.06% | -17.4% |
| Q3 2017 | $1,266,000 | +1.9% | 109,646 | +3.1% | 0.07% | -33.0% |
| Q2 2017 | $1,242,000 | +77.9% | 106,324 | +87.9% | 0.10% | +49.3% |
| Q1 2017 | $698,000 | +8.7% | 56,585 | +20.0% | 0.07% | -11.5% |
| Q4 2016 | $642,000 | -39.4% | 47,157 | -11.4% | 0.08% | -44.7% |
| Q3 2016 | $1,059,000 | +51.1% | 53,229 | -1.6% | 0.14% | +42.4% |
| Q2 2016 | $701,000 | -1.0% | 54,072 | -28.6% | 0.10% | +125.0% |
| Q1 2016 | $708,000 | -13.6% | 75,742 | +87.5% | 0.04% | -57.7% |
| Q4 2015 | $819,000 | – | 40,395 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
| X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
| KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
| ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
| Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
| HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
| DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
| WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
| FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |